The Impact of LUTS on HRQL, Anxiety, Depression and Treatment Seeking


Introduction and Objectives: Multiple LUTS frequently co-occur, but little is known about the prevalence and patient impact of symptom combinations. A large, multi-country epidemiological study examined the prevalence and impact of LUTS in men and women over 40 in the US, UK, and Sweden.

Treatment of Chronic Cystitis Using Intravesical Silics


Introduction and Objective: Treatment of chronic cystitis remains a significant problem in urology. While treating chronic cystitis we should perform intravesical instillations. Suspension of silics is interesting in this field. Silics–derivative of highly disperse silica–are the preparation with sorbtive properties registered in Ukraine. Silics wasn’t applied in urology earlier. Our study is aimed at the effectiveness and endurance estimation of silics application in patients with chronic cystitis in the acute stage.

Darifenacin Effectively Relieves Symptoms In Patients Regardless of Baseline Severity of Overactive Bladder (OAB)

Introduction and Objectives

Severity of OAB symptoms (Sx) eg incontinence episodes (IEs), urgency, frequency and nocturia varies between pts.

Cost-Utility Analysis of Sacral Nerve Stimulation and Botulinum-A for the Treatment of Urinary Urge Incontinence in Women 65 and Older

Introduction and Objectives

Urgency is the fundamental symptom of overactive bladder syndrome (OAB),1 and is regarded as a driver for many other OAB symptoms.2

Presence of Cardiovascular and Central Nervous System Comorbidities in Patients with Overactive Bladder (OAB) Disorder


Introduction and Objectives: OAB is common in older patients, as are comorbidities that can impact a patient's risk for experiencing AEs. Risk of AEs could also impact a physician’s OAB treatment decisions. Most antimuscarinic agents used in OAB treatment are nonselective and may have adverse cardiovascular (CV) and central nervous system (CNS) effects. Our study objective was to identify the proportion of OAB patients potentially at risk for AEs by assessing important comorbidities (focus on CV and CNS) and concomitant drug use (focus on drugs with known CNS effects). We also sought to assess the impact on OAB treatment decisions, by evaluating the presence of comorbidities and concomitant drug use among treated and untreated OAB patients.

UIJ Volume 1 2008

UIJ Volume 4 2011

UIJ Volume 2 2009

UIJ Volume 3 2010

UIJ Volume 5 2012